Innovative Technologies for Informative Data
Synexa utilizes technology platforms that are tailored to assess biomarkers across the biological continuum.
We use innovative approaches and performance qualified equipment to answer client-specific questions related to biomarkers at each level of this continuum and we have extensive experience in analysing matrices drawn from almost any matrix available.
Our platforms and analytical techniques are harmonised across all our sites to ensure consistently high-quality data from all locations. All assays are developed and validated according to the regulatory guidelines for each platform, ensuring that data generated is comparable and clinically-relevant.
Our technology platforms include:
- Meso Scale Discovery
- Cytometric Bead Array
- Fluorescence and Luminescence-based assays
- Protein arrays
- Multicolor flow cytometry
- Cell culture assays
- Fluorescent in situ hybridization/FISH
- Gene expression profiling (NanoString®)
- qPCR & RT-qPCR
- PCR expression array